Christopher Lau

Weill Cornell Medicine

Papers

2

Total Citations

30

H-Index

2

About

Christopher Lau is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His landmark multicenter, randomized controlled trial on robotic-assisted thoracic surgery (RATS) for clinical N2 stage non-small cell lung cancer patients demonstrated that this approach significantly reduces perioperative complications while achieving long-term survival outcomes comparable to traditional posterolateral thoracotomy. This influential study, cited 27 times, has helped establish RATS as a viable alternative for advanced-stage lung cancer patients. Lau has also investigated the benefits of digital chest drainage systems in robotic-assisted lung resections, showing how modern technology can further enhance postoperative recovery. His work bridges the gap between surgical innovation and evidence-based practice, providing crucial data that supports the adoption of robotic techniques in thoracic oncology. Through rigorous clinical trials and comparative effectiveness research, Lau continues to shape the future of lung cancer surgery, offering patients less invasive options without compromising oncologic outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
30
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted thoracic surgery reduces perioperative complications and achieves a similar long-term survival profile as posterolateral thoracotomy in clinical N2 stage non-small cell lung cancer patients: a multicenter, randomized, controlled trial
27 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Weill Cornell Medicine

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago